About Serine/arginine-rich splicing factor 6
Serine/arginine-rich splicing factor 6 (SRSF6) is a protein
from Homo sapiens identified by UniProt accession
Q13247, 344 residues long.
MolForge cross-references it against 0 known binders and
123 disease associations.
Target properties
| Protein name | Serine/arginine-rich splicing factor 6 |
| UniProt accession | Q13247 |
| Gene | SRSF6 |
| Organism | Homo sapiens |
| Length | 344 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (123)
Diseases linked to this target (Open Targets).
- mean platelet volume · score 0.33
- body mass index · score 0.21
- mathematical ability · score 0.20
- self reported educational attainment · score 0.19
- mood instability measurement · score 0.18
- smoking status measurement · score 0.18
- lymphocyte count · score 0.16
- body fat percentage · score 0.16
- seropositivity measurement · score 0.16
- Chlamydia pneumoniae seropositivity · score 0.16
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13247-F1 | alphafold | PREDICTED | 62.58 | — |
Amino-acid sequence (344 residues)
MPRVYIGRLS YNVREKDIQR FFSGYGRLLE VDLKNGYGFV EFEDSRDADD AVYELNGKEL CGERVIVEHA RGPRRDRDGY SYGSRSGGGG YSSRRTSGRD KYGPPVRTEY RLIVENLSSR CSWQDLKDFM RQAGEVTYAD AHKERTNEGV IEFRSYSDMK RALDKLDGTE INGRNIRLIE DKPRTSHRRS YSGSRSRSRS RRRSRSRSRR SSRSRSRSIS KSRSRSRSRS KGRSRSRSKG RKSRSKSKSK PKSDRGSHSH SRSRSKDEYE KSRSRSRSRS PKENGKGDIK SKSRSRSQSR SNSPLPVPPS KARSVSPPPK RATSRSRSRS RSKSRSRSRS SSRD
Explore Serine/arginine-rich splicing factor 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets